These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 18572481

  • 1. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B, Bendtzen K.
    Ugeskr Laeger; 2008 Jun 09; 170(24):2108-10. PubMed ID: 18572481
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Higashida J, Wun T, Schmidt S, Naguwa SM, Tuscano JM.
    J Rheumatol; 2005 Nov 09; 32(11):2109-15. PubMed ID: 16265687
    [Abstract] [Full Text] [Related]

  • 3. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F, Murdaca G, Ghio M, Indiveri F.
    Autoimmun Rev; 2005 Nov 09; 4(8):537-41. PubMed ID: 16214092
    [Abstract] [Full Text] [Related]

  • 4. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
    MMW Fortschr Med; 2002 May 16; 144(20):65. PubMed ID: 12119893
    [No Abstract] [Full Text] [Related]

  • 5. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2012 May 16; 10(117):37-44; quiz 2 p following 44. PubMed ID: 22538522
    [No Abstract] [Full Text] [Related]

  • 6. Autoimmune diseases. The B cell slayer.
    Matthews R.
    Science; 2007 Nov 23; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract] [Full Text] [Related]

  • 7. Management of rheumatoid arthritis.
    Handa R.
    Natl Med J India; 2004 Nov 23; 17(3):143-51. PubMed ID: 15253402
    [Abstract] [Full Text] [Related]

  • 8. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO.
    Bull NYU Hosp Jt Dis; 2008 Nov 23; 66(3):210-5. PubMed ID: 18937634
    [Abstract] [Full Text] [Related]

  • 9. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F, Isenberg DA.
    Handb Exp Pharmacol; 2008 Nov 23; (181):163-81. PubMed ID: 18071946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Roos JC, Ostor AJ.
    N Engl J Med; 2006 Nov 09; 355(19):2046-7; author reply 2048. PubMed ID: 17093259
    [No Abstract] [Full Text] [Related]

  • 13. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
    Choy E.
    Cytokine; 2006 Nov 09; 28(4-5):158-61. PubMed ID: 15588689
    [Abstract] [Full Text] [Related]

  • 14. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY, Browning JC, Larsen F, Hsu S.
    Dermatol Online J; 2008 Sep 15; 14(9):12. PubMed ID: 19061594
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunological therapies for rheumatoid arthritis.
    Edwards CJ.
    Br Med Bull; 2005 Sep 15; 73-74():71-82. PubMed ID: 16174791
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
    Renato GM.
    Ann N Y Acad Sci; 2009 Sep 15; 1173():729-35. PubMed ID: 19758222
    [Abstract] [Full Text] [Related]

  • 20. Targeted therapies for patients with rheumatoid arthritis.
    Oliver S, Mooney J.
    Prof Nurse; 2002 Aug 15; 17(12):716-20. PubMed ID: 12229045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.